Protective human MAbs to a highly conserved conformational determinant on influenza M2e

被引：0

作者：

Grandea, Andres ^{[1
]}

Olsen, Ole ^{[1
]}

Cox, Tom ^{[1
]}

Renshaw, Mark ^{[1
]}

Hammond, Philip ^{[1
]}

Chan-Hui, Po-Ying ^{[1
]}

Mitcham, Jennifer ^{[1
]}

Cieplak, Witold ^{[1
]}

Stewart, Shaun ^{[2
]}

Grantham, Michael ^{[2
]}

Pekosz, Andrew ^{[2
]}

Hatta, Masato ^{[3
]}

Kawaoka, Yoshihiro ^{[3
]}

Moyle, Matthew ^{[1
]}

机构：

[1] Theraclone Sci Inc, Seattle, WA USA

[2] Johns Hopkins Univ, Baltimore, MD USA

[3] Univ Wisconsin, Madison, WI 53706 USA

来源：

JOURNAL OF IMMUNOLOGY | 2010年 / 184卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

38.14

引用

页数：1

共 50 条

[41] Tyrosine-Based Cross-Linking of Peptide Antigens to Generate Nanoclusters with Enhanced Immunogenicity: Demonstration Using the Conserved M2e Peptide of Influenza A
Wilks, Logan R.
Joshi, Gaurav
Grisham, Megan R.
Gill, Harvinder Singh
ACS INFECTIOUS DISEASES, 2021, 7 (09): : 2723 - 2735
[42] Protective efficacy of a bacterially produced modular capsomere presenting M2e from influenza: Extending the potential of broadly cross-protecting epitopes
Wibowo, Nani
Hughes, Fiona K.
Fairmaid, Emily J.
Lua, Linda H. L.
Brown, Lorena E.
Middelberg, Anton P. J.
VACCINE, 2014, 32 (29) : 3651 - 3655
[43] HBc particles carrying multiple copies of influenza M2e peptides into the major immunodominant region as a candidate influenza vaccine
Blokhina, Elena
Kuprianov, Victor
Ravin, Nikolai
JOURNAL OF BIOTECHNOLOGY, 2014, 185 : S103 - S103
[44] Safe Recombinant Outer Membrane Vesicles that Display M2e Elicit Heterologous Influenza Protection
Watkins, Hannah C.
Rappazzo, C. Garrett
Higgins, Jaclyn S.
Sun, Xiangjie
Brock, Nicole
Chau, Annie
Misra, Aditya
Cannizzo, Joseph P. B.
King, Michael R.
Maines, Taronna R.
Leifer, Cynthia A.
Whittaker, Gary R.
DeLisa, Matthew P.
Putnam, David
MOLECULAR THERAPY, 2017, 25 (04) : 989 - 1002
[45] Delivery of gold nanoparticle-conjugated M2e influenza vaccine in mice using coated microneedles
Nesovic, Lazar D. D.
Roach, Carsen J. J.
Joshi, Gaurav
Gill, Harvinder Singh
BIOMATERIALS SCIENCE, 2023, 11 (17) : 5859 - 5871
[46] Effect of M2e peptide-gold nanoparticle conjugates on development of anti-influenza antibodies
Dykman, Lev A.
Staroverov, Sergey A.
Fomin, Alexander S.
GOLD BULLETIN, 2018, 51 (04): : 197 - 203
[47] Development of live attenuated Bordetella pertussis strains expressing the universal influenza vaccine candidate M2e
Li, Rui
Lim, Annabelle
Ow, Stephanie T. L.
Phoon, Meng Chee
Locht, Camille
Chow, Vincent T.
Alonso, Sylvie
VACCINE, 2011, 29 (33) : 5502 - 5511
[48] Evaluation of an inactivated Salmonella-recombinant vaccine expressing type A influenza M2e epitopes.
Gaona-Ramirez, G.
Layton, S. L.
Wolfenden, A. D.
Wolfenden, R. E.
Pumford, N. R.
Tellez, G.
Hargis, B. M.
POULTRY SCIENCE, 2008, 87 : 80 - 81
[49] Strategies and Limitations in Dendrimeric Immunogen Synthesis. The Influenza Virus M2e Epitope as a Case Study
Kowalczyk, Wioleta
de la Torre, Beatriz G.
Andreu, David
BIOCONJUGATE CHEMISTRY, 2010, 21 (01) : 102 - 110
[50] A Universal Influenza Vaccine Using an M2e/NP Fusion Protein Linked to Immunostimulatory Sequences (ISS)
Higgins, D.
dela Cruz, T.
Milley, R.
Hillebrand, A.
Amuel, C.
Van Nest, G.
VACCINE, 2008,

← 1 2 3 4 5 →